Skip to content
OpenCapital
Get started

Celldex Therapeutics CLDX Invested capital

Discontinued — last reported Q1 '26

Invested capital at other companies

Travel + Leisure logo
Travel + LeisureTNL
18.8%+0.1pp
Belden logo
BeldenBDC
12.2%+0.5pp
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
3.4%+1.8pp
Liberty Broadband Corporation logo
Liberty Broadband CorporationLBRDK
-0.3%-0.1pp
Archer Aviation logo
Archer AviationACHR
-129.7%-62.3pp
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
17.5%+14.2pp

Other financials

Income statement

See full
Revenue$15.0K-97.8%
Operating income-$84.4M-34.6%
Net income-$78.7M-46.3%
EPS (diluted)-$1.18-45.7%

Balance sheet

See full
Cash & equivalents$35.7M+109%
Total debt$1.9M-44.3%
Total equity$456.2M-35.1%
Total assets$511.3M-30.9%

Cash flow

See full
Operating cash flow-$65.6M-20.6%
CapEx$1.6M+518%
Free cash flow-$67.2M-23.0%

Valuation

See full
Market cap$2.59B+75.2%
Enterprise value$2.55B+74.4%
P/S2,989.2×+2,794×

Profitability

See full
Operating margin-35,688.5%-39,114pp
Net margin-32,753.6%-35,519pp
FCF margin-26,125.8%-28,907pp

Returns & leverage

See full
Return on equity-48.9%-498pp
Debt / equity0×0.0×
Current ratio8.9×-12.7×

Where this comes from

Calculated from Celldex Therapeutics’s reported figures.

$1.9Mtotal debt+$456.2Mtotal stockholders equity−$35.7Mcash and equivalents=$422.41M

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celldex Therapeutics's invested capital?
Celldex Therapeutics (CLDX) reported invested capital of $422.41M in Q1 2026.
How has Celldex Therapeutics's invested capital changed year-over-year?
Celldex Therapeutics's invested capital decreased by 38.7% year-over-year, from $689.27M to $422.41M.
What is the long-term trend for Celldex Therapeutics's invested capital?
Over 5 years (2020 to 2025), Celldex Therapeutics's invested capital has grown at a 24.3% compound annual growth rate (CAGR), from $169M to $500.63M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).